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Abstract Metabolomics involves the unbiased quantita-
tive and qualitative analysis of the complete set of
metabolites present in cells, body fluids and tissues (the
metabolome). By analyzing differences between metabol-
omes using biostatistics (multivariate data analysis; pattern
recognition), metabolites relevant to a specific phenotypic
characteristic can be identified. However, the reliability of
the analytical data is a prerequisite for correct biological
interpretation in metabolomics analysis. In this review the
challenges in quantitative metabolomics analysis with
regards to analytical as well as data preprocessing steps are
discussed. Recommendations are given on how to optimize
and validate comprehensive silylation-based methods from
sample extraction and derivatization up to data prepro-
cessing and how to perform quality control during meta-
bolomics studies. The current state of method validation
and data preprocessing methods used in published litera-
ture are discussed and a perspective on the future research
necessary to obtain accurate quantitative data from com-
prehensive GC-MS data is provided.
Keywords Quantitative metabolomics  Method
validation  Data preprocessing  Quality control  Gas
chromatography mass spectrometry
1 Introduction
Functional genomics technologies (transcriptomics, preo-
teomics, metabolomics) are increasingly important in the
fields of microbiology, plant and medical sciences, and are
increasingly used in a systems biology approach. Meta-
bolomics evolved from conventional profiling techniques
and the view to study organisms or biological systems as
integrated and interacting systems of genes, proteins,
metabolites, cellular and pathway events, the so-called
systems biology approach (van Greef et al. 2004a). Meta-
bolomics involves the unbiased quantitative and qualitative
analysis of the complete set of metabolites present in cells,
body fluids and tissues (the metabolome). Biostatistics
(multivariate data analysis; pattern recognition) plays an
essential role in analyzing differences between metabolo-
mes, enabling the identification of metabolites relevant to a
specific phenotypic characteristic.
In analogy with other functional genomics techniques, a
comprehensive, generally non-targeted approach is used to
gain new insights and a better understanding of the bio-
logical functioning of a cell or organism. To answer
biological questions, it is crucial that all steps from the
clear definition of the biological questions, the choice
of a suitable experimental design, the proper sampling
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procedure, sample preparation, data acquisition and data
processing are addressed to obtain quantitative data, which
can be then used for data analysis and final biological
interpretation (Fig. 1). Obviously, optimization, validation
and proper quality control of analytical methods is of key
importance.
1.1 Strategies in metabolomics related research
In present-day research several different analytical strate-
gies are applied for the analysis of a wide range of
metabolites, i.e. metabolic target analysis, metabolic pro-
filing, metabolic fingerprinting, metabonomics and meta-
bolomics (Table 1). Depending on the biological question,
different analytical approaches are required and different
demands are posed on analytical performance (detection
limits, precision, accuracy, etc.).
The terminology in metabolic research is still not stan-
dardized and different definitions of the terms are proposed
in different papers. Metabolic target analysis and metabolic
profiling are commonly used strategies in classically
hypothesis-driven metabolic research, where the interest is
focused on a limited number of metabolites, or a certain
compound class or metabolic pathway. Due to the selective
sample pretreatment and/or sample cleanup used in this
approach, low detection limits and high precision and
accuracy can be achieved. For rapid screening and classi-
fication of samples identification and quantification of each
individual metabolite is not always necessary and metabolic
fingerprinting approaches are commonly applied. Meta-
bolomics is the comprehensive non-target analysis of all (or
at least as many as possible) metabolites in a biological
system. Ultimately, metabolomics analysis would provide
information on the absolute concentrations of all extractable
metabolites in a sample (absolute quantification), as this
would help to make data comparable. However, due to
practical limitations, e.g. the absence of standard reference
materials for metabolomics analysis, metabolites are mostly
quantified using relative quantification, i.e. determining the
response ratio between the metabolite and an internal
standard or other metabolite. In addition, unidentified
metabolites present in a sample can also be quantified using
relative quantification. Metabonomics is sometime distin-
guished as a separate approach in metabolomic research.
Metabonomics is defined as the quantitative measurement
of the dynamic multiparametric metabolic response of liv-
ing systems to pathophysiological stimuli or genetic mod-
ification (Nicholson et al. 1999; Nicholson and Lindon
2008) In practice, the terms metabolomics and metabo-
nomics are often used interchangeably, and the analytical
Fig. 1 Schematic of a typical
workflow in metabolomics
Table 1 Analytical strategies for metabolic research
Metabolite target
analysis
Quantitative (absolute or relative) analysis of one or few target metabolites. Typical strategy: selective sample
pretreatment followed by separation (GC, LC, CE) coupled to sensitive selective detection
Metabolic profiling Quantitative (absolute or relative) and qualitative (identification) multi-component analyses that define or describe
metabolic patterns for a group of metabolically or analytically related metabolites (Horning and Horning 1971).
Typical strategy: sample pretreatment selective for compound class or compounds from certain pathway followed
by separation coupled to MS detection
Metabolic fingerprinting High throughput screening of samples to provide sample classification. Generally no quantification (or only relative
quantification) and no identification of individual metabolites (Dunn and Ellis 2005; Fiehn 2002) Typical strategy:
Simple sample pretreatment followed by NMR, FTIR, or direct infusion mass spectrometry (DIMS).
Metabolomics
(Metabonomics)
Quantitative (mostly relative quantification) and qualitative analysis of the complete set of metabolites present in a
biological system (cells, body fluids, tissues). Typical strategy: generic sample pretreatment followed by separation
coupled to MS detection
308 M. M. Koek et al.
123
and modeling procedures are the same. Throughout this
review the terminology and definitions as described in
Table 1 are used.
1.2 Analytical techniques in metabolomics research
Development of generic methodologies to analyze the com-
plete metabolome, or at least as many metabolites as possible,
is very challenging considering the complexity of the
metabolome. The extent of the full metabolome is dependent
on the organism studied, varying from a few hundred
endogenous metabolites for microorganisms (Forster et al.
2003; Hall et al. 2002) to a few thousands endogenous human
metabolites (without taking lipids into account). For lipids
tens of thousands different metabolites might be expected,
but a definite estimation is not possible at the moment. In
addition, more than 100,000 small molecules can be expected
to be present in humans due to the consumption of food,
drugs, etc. (Wishart et al. 2007). Moreover, metabolites
consist of a wide variety of compound classes with different
physical and chemical properties and are present in a large
range of concentrations. For example, in human-blood-
plasma samples, normal glucose concentrations are as high as
5000 lM (925 mg/l), while estradiol has a concentration of
approximately 0.00009 lM (24 ng/l) (Wishart et al. 2009),
covering a range of more than seven decades.
Currently, the main analytical techniques used for the
analysis of the metabolome are nuclear magnetic resonance
spectroscopy (NMR) and hyphenated techniques such as
gas chromatography (GC) and liquid chromatography (LC)
coupled to mass spectrometry (MS). In addition, other
combinations are possible, e.g. capillary electrophoresis
(CE) coupled to MS or LC coupled to electrochemical
detection. Alternatively, Fourier transform infrared spec-
troscopy and direct infusion mass spectrometry (DIMS)
have been applied (Dunn and Ellis 2005; van Greef et al.
2004a; Greef and Smilde 2005; Lindon et al. 2007) without
any prior separation, except for eventual sample prepara-
tion. NMR, FTIR and DIMS are high throughput methods
and require minimal sample preparation and may be pre-
ferred techniques for metabolic fingerprinting. However,
the obtained spectra are composed of the signals of very
many metabolites and elucidation of these complex spectra
can be very complicated. In addition, detection limits for
NMR and FTIR are much higher than for MS-based
techniques, limiting the application range to metabolites
present in higher concentrations. Therefore hyphenated
techniques, e.g. GC-MS, LC-MS and CE-MS, are generally
preferred in metabolomics to allow quantification and
identification of as many as possible (individual) metabo-
lites. However none of the individual methods will cover
the full metabolome and a combination of techniques is
necessary to ultimately measure the full metabolome.
1.3 Comprehensive analysis with GC-MS
GC-MS is a very suitable technique for comprehensive
analysis, as it combines a high separation efficiency with
versatile, selective and sensitive mass detection. In Table 2
an overview of GC-based applications in metabolomics
research is presented from different fields of research,
such as microbiology, plant- and medical science (phar-
macology, clinical research). Only papers targeting more
than three different metabolite classes were included in the
table. Nearly all GC-based metabolomics applications
combine GC with MS detection using electron ionization
(EI). As the full scan response in EI mode is approximately
proportional to the amount of compound injected, i.e. more
or less independently of the compound, all compounds
suitable for GC analysis are detected non-discriminatively.
Furthermore, problems with ion suppression of co-eluting
compounds as observed in LC-MS are virtually absent in
GC-EI-MS. Also, the assignment of the identity of peaks
via a database of mass spectra is straightforward, due to the
extensive and reproducible fragmentation patterns obtained
in full-scan mode. In addition, the fragmentation pattern
can be used to identify or classify unknown metabolites.
Volatile, low-molecular-weight metabolites can be sam-
pled and analyzed directly, e.g. in breath analysis often a
direct approach without derivatization is used (Pauling et al.
1971). However, many metabolites contain polar functional
groups and are thermally labile at the temperatures required
for their separation or are not volatile at all. Therefore,
derivatization prior to GC analysis is needed to extend the
application range of GC based methods. The majority of GC
methods reviewed (Table 2) rely on derivatization with an
oximation reagent followed by silylation, or solely silylation.
As silylation reagents are the most versatile and universally
applicable derivatization reagents, these are most suitable for
comprehensive GC(-MS) analysis. Only few authors used an
alternative derivatization, e.g. chloroformates (Qiu et al.
2007) or no derivatization at all. Therefore this review
focuses on GC-MS methods using oximation and subse-
quently silylation or solely silylation prior to analysis.
1.4 Obtaining quantitative data
Ultimately the goal in metabolomics analysis is to identify
and quantify all metabolites in order to find answers to
biological questions. This review focuses on how quanti-
tative data can be obtained from silylation-based GC-MS
methods, thereby covering sample preparation, data
acquisition and data processing. The challenges in com-
prehensive GC-MS based metabolomics analysis are dis-
cussed and recommendations on method development, data
processing, method validation and quality control during
studies are given. Validation and data-processing strategies
Quantitative metabolomics 309
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Table 2 Overview of GC(-MS) based metabolomics papers
Authors Technique Focusb Matrix Validation parametersc
Aura et al. (2008) S-GC-MS & S-GC9GC-MS 7 feaces –
Birkemeyer et al. (2005) GC-MS 4 microbial –
Chang et al. (2006) OS-GC-MS 7 plant –
Coucheney et al. (2008) OS-GC-MS 3, 6, 7 microbial 4
De Souza et al. (2006) OS-GC-MS 6 microbial –
Fan et al. (1993) S-GC-MS 7 plant 3, 4
Fan et al. (2001) GC-MS 7 plant –
Fiehn et al. (2000b) OS-GC-MS 5 plant –
Fiehn et al. (2000a) OS-GC-MS 1, 2, 3, 4, 6 plant 2, 4
Fiehn (2003) OS-GC-MS 6 plant –
Fiehn et al. (2008) OS-GC-MS 3, 4, 6, 7 plant –
Gullberg et al. (2004) OS-GC-MS 1 plant 4
Guo and Lidstrom (2008) OS-GC 9 GC-MS 5, 6 microbial 2
Hiller et al. (2009) OS-GC-MS 6 microbial 2a
Hope et al. (2005a) S-GC 9 GC-MS 7 plant –
Huang and Regnier (2008) OS-GC 9 GC-MS 4 serum –
Humston et al. (2010) SPME(HS)- GC 9 GC-MS 6, 7 plant –
Humston et al. (2008) OS-GC 9 GC-MS 6, 7 microbial –
Jeong et al. (2004) OS-GC-MS 7 plant –
Jiye et al. (2008) OS-GC-MS 6, 7 urine –
Jonsson et al. (2004) OS-GC-MS 6 plant –
Jonsson et al. (2005) OS-GC-MS 6 plant –
Jonsson et al. (2006) OS-GC-MS 6 urine –
Koek et al. (2006) OS-GC-MS 1, 2, 3, 4 microbial 2, 3, 4, 5, 6, 7
Koek et al. (2008) OS-GC 9 GC-MS 1, 2, 3, 4 serum/plasma 1, 2, 3, 4, 6
Koek et al. (2010a) S-GC-MS 2, 3, 7 mouse CSF 2, 3, 4, 5
Koek et al. (2010b) OS-GC 9 GC-MS 6, 7 liver 4
Kuhara (2001) OS-GC-MS 7 urine –
Kusano et al. (2007) OS-GC 9 GC-MS 6 plant 4
Lee and Fiehn (2008) OS-GC-MS 1, 7 microbial –
Li et al. (2009) S-GC 9 GC-MS 6 plasma 4
Lu et al. (2008) OS-GC-MS 6, 7 plasma 4
Ma et al. (2008) S-GC-MS 2, 6 plant –
Martins et al. (2004) OS-GC-MS 2, 3 microbial 4
Matsumoto and Kuhara (1996) S-GC-MS 7 urine –
Mills and Walker (2001) SPME(HS)-GC-MS 7 urine –
Mohler et al. (2007) OS- GC 9 GC-MS 6, 7 yeast –
Mohler et al. (2006) OS-GC 9 GC-MS 1, 2, 3, 6 yeast 4
Mohler et al. (2008) OS-GC 9 GC-MS 6 microbial –
Morgenthal et al. (2005) OS-GC-MS 1, 2, 3, 6 plant 4
O’Hagan et al. (2005) OS-GC-MS 3, 4 serum/yeast 4
O’Hagan et al. (2007) OS-GC 9 GC-MS 3 serum –
Oh et al. (2008) S-GC 9 GC-MS 6 serum –
Ong et al. (2009) S-GC-MS 7 liver 4
Pan et al. (2010) OS-GC-MS 1 liver 2, 3, 4, 6, 7
Pasikanti et al. (2008) S-GC-MS 4, 6 urine 2a, 4, 5, 7
Pauling et al. (1971) HS-GC-FID 3, 4 urine, breath 4
Pierce et al. (2006b) S-GC 9 GC-MS 6 plant –
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applied in published comprehensive GC-based metabolo-
mics methods are evaluated. Moreover, a perspective on
the future research necessary to obtain accurate quantita-
tive data from comprehensive GC-MS data is provided.
2 Recommendations on method development, data
processing, validation and quality control
The reliability and suitability of sample preparation, data
acquisition, data preprocessing and data analysis are pre-
requisites for correct biological interpretation in meta-
bolomics studies. The significance of differences between
samples can only be determined when the performance
characteristics of the entire method (from sample prepa-
ration to data preprocessing) are known. Therefore it is
important to perform method validation to assess the per-
formance and the fitness-for-purpose of a method or
analytical system for metabolomic research, including
ultimately error models per metabolite.
In the following sections the challenges and recom-
mendations for method development and data processing
and some commonly used data analysis tools are discussed.
Furthermore, strategies for method validation and quality
control are provided.
2.1 Analytical method development and analysis
The development of silylation based GC-MS methods poses
serious challenges for analytical chemists considering the
large range of compound classes and the large differences in
concentrations within and between biological samples.
Inconsistencies in quantification of metabolites can arise
from many sources during sampling, sample storage, sam-
ple extraction, derivatization, analysis and/or detection. For
example, during sampling, sample storage and extraction of
Table 2 continued
Authors Technique Focusb Matrix Validation parametersc
Pierce et al. (2006a) S-GC 9 GC-MS 6 urine –
Qiu et al. (2007) ECF-GC-MS 1, 2, 3, 4 urine 2, 3, 4, 6
Ralston-Hooper et al. (2008) OS-GC 9 GC-MS 7 invertebrates –
Roessner et al. (2000) OS-GC-MS 1, 2, 3, 4 plant 2, 3, 4
Roessner et al. (2001a) OS-GC-MS 6 plant –
Roessner et al. (2001b) OS-GC-MS 6 plant 4
Schauer et al. (2005) OS-GC-MS 5 all –
Sangster et al. (2006) OS-GC-MS 6 plasma –
Schmarr and Bernhardt (2010) SPME(HS)- GC 9 GC-MS 6 plant –
Shellie et al. (2005) OS-GC 9 GC-MS 6 mouse spleen –
Sinha et al. (2004b) OS-GC 9 GC-MS 6 urine –
Strelkov et al. (2004) OS-GC-MS (polar) ? S-GC-MS (apolar metabolites) 1, 2, 3, 4 microbial 4
Styczynski et al. (2007) MCF-GC-MS 6 microbial –
Tian et al. (2008) S-GC-FID/MS 3, 6 microbial 2a, 3a, 4a, 6a
Tianniam et al. (2008) OS-GC-MS 7 plant –
Vikram et al. (2004) HS-GC-MS 7 apples –
Villas-Boˆas et al. (2003) MCF-GC-MS 2, 3 microbial 2, 4, 6
Villas-Boˆas et al. (2005) OS-GC-MS/MCF-GC-MS 1 yeast 3
Wagner et al. (2003) OS-GC-MS 5, 6 plant –
Weckwerth et al. (2004a) OS-GC-MS 4, 6 plant –
Weckwerth et al. (2004b) OS-GC-MS 1, 2, 3, 4, 6 plant 3, 4
Welthagen et al. (2005) OS-GC 9 GC-MS 3, 6 mouse spleen 4
Wishart et al. (2008) OS-GC-MS 7 CSF –
Zhang et al. (2007) OS-GC-MS 3, 4 urine 2, 4, 5, 6, 7
O oximation, S silylation, CF chloroformate derivatization, HS headspace sampling, SPME solid phase micro extraction
a Validation parameter only assessed in academic standard, i.e. standard without matrix
b Focus: 1 = extraction, 2 = derivatization, 3 = analysis, 4 = detection/quantification, 5 = identification, 6 = data preprocessing and analy-
sis, 7 = application
c Analytical validation parameters: 1 = selectivity (peak capacity), 2 = calibration model, 3 = accuracy (recovery), 4 = repeatability,
5 = intermediate precision, 6 = LLOQ/LLOD, 7 = stability
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the metabolites, undesired changes in metabolite composi-
tion may occur due to for example enzyme activity, high
reactivity and/or breakdown of metabolites. One way to
avoid this is to use ‘snapshot’ sampling, i.e. fast cooling of
the sample to low temperatures, maintain low storage
temperatures (-80C) and/or use low temperatures and
appropriate additives to inhibit enzyme activity during
extraction. Furthermore, irreproducible extraction and/or
derivatization as well as degradation of derivatized
metabolites in the analytical system are common problems
that can introduce errors in the quantification. To detect the
occurrence of these problems, an extensive set of test
metabolites with different functional groups, polarity,
molecular mass, etc. is required to optimize the method
performance along the entire trajectory from sampling up to
detection.
In a previous paper we introduced three performance
classes based on the differences in reactivity towards sily-
lation and the stability of derivatized metabolites (Koek et al.
2006) Performance class-1 metabolites are metabolites
containing hydroxylic and carboxylic functional groups,
such as sugars, fatty acids and organic acids. The analytical
performance for these metabolites is generally very satis-
factory with performance characteristics that fit the FDA
requirements for target analysis in bioanalysis. Performance
class-2 type metabolites, metabolites containing amine or
phosphoric functional groups, can also be measured with
satisfactory derivatization efficiencies, repeatability and
intermediate precision. However the analysis of these
metabolites is more critical compared to class-1 metabolites,
when the method is not carried out under ‘optimal’ condi-
tions. Metabolites with amide, thiol or sulfonic functional
groups, so-called performance class-3 compounds, are more
difficult to derivatize and analyze. We recommend using
representative metabolites from all three performance clas-
ses, preferably isotopically labeled and with different vola-
tilities and molecular mass for method optimization and
validation. It should be noted that the mass difference
between the labeled and naturally occurring metabolite must
be sufficient to avoid isotopic interference from the naturally
occurring metabolite in the quantification of the reference
compound. The amount of mass difference needed depends
on the amount of silyl groups after derivatization, the ratio
between the naturally occurring metabolite and the labeled
metabolite and the mass fragmentation of the metabolites.
For example, phenylalanine can be distinguished from
phenylalanine-d5 in most extracts by using mass fragments
m/z 192 (endogenous) and m/z 197 (labeled) for quantifica-
tion, as these fragments contain five deuterium and only one
silicon atom. However, due to the large amounts of endog-
enous glucose in matrices such as blood plasma, the accurate
quantification of glucose-d7 is (almost) impossible due to
isotopic interference, using m/z 319 and m/z 323 (highest
significant mass fragments in EI spectrum) as quantification
masses. By adding labeled metabolites at different stages
during from sample workup till injection, extraction and
derivatization can be optimized to maximize the coverage of
the entire analytical method (and minimize errors due to
insufficient and/or irreproducible extraction and/or deriva-
tization and artifact formation). Silylation has the advantage
of a wide application range (Blau and Halket 1993; Knapp
1979). In metabolomics, trimethylsilylation (TMS) reagents,
such as N-methyltrimethylsilyltrifluoroacetamide (MSTFA)
and N,O-bis(trimethylsilyl)acetamide (BSA), are most
commonly used. Both MSTFA and BSA are general purpose
reagents with a wide application range and comparable
silylation strength. In some cases trimethylsilylchlorosilane
is added as a possible catalyst. Furthermore, several other
reagents or mixes of reagents are available with more
selective reagents, e.g. trimethylsilylimidazole (TMSI) or a
mix of hexamethyldisilazane (HMDS) with TMCS and a mix
of TMSI/BSA/TMCS, all developed to derivatize (sterically
hindered) hydroxylgroups.
Early on in the development of our derivatization method
as described in Koek et al. (2006), several derivatization
reagents were compared, e.g. MSTFA, MSTFA with 1%
TMCS, BSA, TMSI and TMSI/BSA/TMCS 3:3:2 (unpub-
lished data). The byproduct of TMSI, i.e. imidazole, eluted as
a (large) tailing peak in the chromatogram, and TMSI did not
improve the recovery or performance (RSD) for typical
targets such as monosaccharides compared to MSTFA. In
our experiments the best results (highest recoveries and
smallest RSDs) were obtained with MSTFA, the addition of
TMCS did not improve the performance. The results with
BSA were for the most part, comparable with the result for
MSTFA, however, the RSDs for sugars were slightly higher.
In addition, the byproduct of MSTFA is more volatile than
the byproduct of BSA and therefore allows for the quantifi-
cation of more volatile metabolites compared to BSA. A
drawback of silylation reagents is their susceptibility
towards hydrolysis. Therefore extracts should be as dry as
possible before derivatization. As an example, only 1 ll of
water in an extract will use up approximately 20 ll of
MSTFA. In addition, derivatized extracts should be kept free
of water after derivatization to avoid hydrolysis of the
derivatized metabolites. By using a bulkier silylgroup, the
hydrolytic stability of derivatized metabolites can be
improved. However, in experiments with N-methyl-N-(tert-
butyldimethylsilyl)trifluoroacetamide (MTBSTFA), sugars
and some amino acids could not be derivatized completely
(not even under extreme conditions) resulting in several
derivates for one metabolite (unpublished data). In addi-
tion, the elution temperature of derivatized metabolites is
increased compared to TMS derivates, limiting the appli-
cation range for large molecules. Still, the use of MTBSTFA
can be useful for identification purposes. Due to a more
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favorable fragmentation behavior EI mass spectra of TBS
derivates contain higher characteristic M-57 (loss of tert-
butyl) peak compared to the M-15 (loss of methyl) found
with TMS derivates.
The derivatization efficiency is an important factor, that
should be addressed during the method optimization, as
metabolites can be only be analyzed reproducibly if the
derivatization efficiency is sufficiently large. Due to the
absence of commercially available reference standards that
are silylized, the recovery cannot be determined by com-
paring the response of a metabolite spiked to a sample prior
to derivatization and a standard solution of a reference
standard. However, the derivatization efficiency can be
estimated by using the assumption that the full scan
response of a metabolite is proportional to the amount of
mass injected. By comparing the response for the deriva-
tized metabolites with the response of n-alkanes as refer-
ence compounds, the derivatization efficiency can be
estimated (Koek et al. 2006).
Due to differences in stability of derivatized metabo-
lites, some metabolites, especially derivatized class 3
metabolites, are more prone to degradation during storage
or decomposition in the analytical system. Also, the degree
of adsorption and/or degradation can vary between differ-
ent samples with different biomass concentrations and
different matrix compositions. For example, the presence
of large amounts of extraction buffer components, such as
HEPES or sulfate can significantly decrease the response of
metabolites, while large amounts of other compounds, such
as glucose or urea, can increase the response (unpublished
results). In addition the extend of these effects can vary
depending on the concentration of the matrix compound
and the class and concentration of the metabolite. In Fig. 2
the matrix enhancement effect of glucose on different
metabolites measured on GC 9 GC-MS is illustrated. In
the ‘conventional’ setup, using a narrow bore thin film
column, the response of the same amount of lysine and
citric acids in extracts with low levels of glucose are lower
compared to extracts with high levels of glucose, due to
reduced adsorption of metabolites on active sites in the
analytical system. In the high capacity setup using a more
inert thicker film column in the second dimension virtually
no adsorption of these metabolites occurs. Consequently,
such matrix effects should be evaluated. This also illus-
trates the importance of an inert analytical system (sample
storage vials, injection liners, analytical columns, etc.) to
minimize adsorption and degradation of especially rela-
tively unstable derivatized metabolites.
2.2 Data processing
Prior to statistical analysis the acquired analytical data
needs to be processed such that equal identity is assigned to
the same variable in each sample. For this purpose, essen-
tially three types of methods are available: target analysis,
peak picking and deconvolution. Each method requires its
own tactics to tackle problems such as peak shift and peak
overlap. The main challenges for data processing are (i) the
amount of data (hundreds up to thousands of peaks in one
sample), (ii) unbiased data processing, (iii) alignment of
peaks shifted along the retention time axis and (iv)
obtaining only one entry for each metabolite.
For target analysis, a list is prepared that contains a
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Fig. 2 Illustration of the matrix enhancement effect of glucose on
different metabolites measured with two different GC 9 GC-MS
configurations. a ‘conventional’ setup with 30 m 9 0.25 mm 9
0.25 lm HP5-MS in the first and 1 m 9 0.1 mm 9 0.1 lm BPX-50
in the second dimension. b ‘high capacity’ setup with 30 m 9
0.25 mm 9 0.25 lm HP5-MS in the first and 2 m 9 0.32 mm 9
0.25 lm BPX-50 in the second dimension. In the ‘conventional’ setup
in extracts with smaller amounts of glucose, the class-2 metabolite
lysine and, to a lesser extent, citric acid adsorb and/or degrade on active
sites present in the analytical system. In the extracts with high levels of
glucose, the response for these metabolites increases, most probably
because active sites are blocked. In the ‘high capacity’ setup using the
more inert thicker film second dimension column the absorption is not
present even at low levels of glucose in the matrix (Koek et al. 2008)
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within which a certain metabolite is expected to appear in
all data files. Software provided by the instrument vendor is
then able to determine the peak area of each metabolite
based on the so called target list. This results in a peak area
per metabolite and per sample. The advantages of this
method are good precision, identities can be assigned
beforehand and only one entry is obtained per peak. Dis-
advantages are that building the target table is time con-
suming and small peaks overlapping with larger peaks are
easily overlooked.
A more comprehensive method that ensures the inclu-
sion of most peaks, if not all, is peak picking. For peak
picking methods such as the second derivative per
m/z channel are used to detect the location of peaks in a
chromatogram. Often, the peak height is then used as an
estimate of the peak area. Methods for peak picking are
automated and therefore much faster than for instance
target analysis if the target list has to be prepared. There are
however many drawbacks: (i) precision is lower, (ii) mul-
tiple entries per metabolite are usually obtained because
peaks found for all m/z value are reported and (iii) the
quality of the final results are difficult to check because the
peak identities are not known. Furthermore, the peaks
require alignment after peak picking due to retention time
shifts. A summary of commonly used alignment techniques
and algorithms is given by Jellema 2009).
The third generic class of data processing methods is
deconvolution, a mathematical method that enhances the
analytical resolution even further. Deconvolution makes use
of the differences in mass-spectral information between
different metabolites to separate overlapping peaks (Fig. 3).
Furthermore, the method reports mass spectra rather than
individual mass signals which offers a great advantage over
peak picking where 20–30 peak areas (corresponding to the
number of m/z values) per metabolite are common. Gener-
ally, in metabolomics research, deconvolution resolves
unresolved peaks and transforms the raw data into peak
tables with integrated peak areas per metabolite and per
sample plus a list of mass spectra. Deconvolution can also be
automated and is therefore faster than target analysis.
Another advantage is that complete mass spectra are reported
that can be used for annotation of peak identities to each
reported peak. In comparison to peak picking the alignment
step can be skipped because deconvolution can be performed
on a complete dataset simultaneously rather than on indi-
vidual chromatograms. However, the lack of a perfect
computer program can result in poor spectra, multiple entries
per metabolite and poor precision. For example, in auto-
mated data processing in GC 9 GC-MS, which requires the
merging of peaks from different modulations originating
from one peak after deconvolution, lower precision was
observed using currently available methods compared to a
targeted approach (Koek et al. 2010b). Actually, automated
deconvolution, peak integration and peak merging is cur-
rently the only possibility to get from raw GC 9 GC-MS
data to a peak list with corresponding areas.
In terms of quality the target analysis results are up till
now the best that can be obtained for any given GC-MS
dataset if a proper target table is prepared. However, it can
easily take more than a full week for an experienced ana-
lyst to produce targeted results for approximately 20–40
samples, because of the large amount of different peaks
(components) present in the data files. However, the
drawback of missing minor peaks in a targeted approach is
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spectrum of peak 3 
Deconvoluted mass 
spectrum of peak 1 
Fig. 3 Example of
deconvolution: three
overlapping peaks were
separated, making use of the
mass spectral information. This
results in a peak table with the
response for all three individual
metabolites and their
corresponding mass spectrum
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probably of much more importance than a reduced preci-
sion which is currently still the case in deconvolution based
methods (in GC-MS and GC 9 GC-MS).
Deconvolution is the most promising method for pro-
cessing of gas chromatography mass spectrometry based
metabolomics data as it fits all requirements: (i) handling
huge datasets, (ii) automated processing, (iii) automatic peak
alignment and (iv) just one quantitative value per metabolite
per sample. Major issues in the development of deconvolu-
tion procedures are still the estimation of the number of
metabolites present in a cluster of peaks and the variability of
the mass spectral information which needs to be assumed
equal for a single metabolite measured in multiple samples.
However, this assumption cannot be met in some cases, for
example, when large differences exist between the concen-
trations of a metabolite in different samples, some masses of
a mass spectrum are outside the linear range, or when peaks
with higher concentration are disturbing the measurements
of nearby low concentration metabolites. These issues need
to be resolved to come to an optimal deconvolution algo-
rithm. Still, it is the authors’ opinion that a deconvolution
approach, in which the chromatograms of all samples are
automatically processed resulting in peak tables and
metabolite spectra, is the most optimal solution.
2.3 Data analysis
Data analysis or statistical analysis is used to extract rele-
vant biological information from the analytical data
obtained. The quantitative aspects of analytical data are not
influenced by data analysis and therefore these were con-
sidered beyond the scope of this paper. However, the
applicability of data analysis tools is largely dependent on
the quality of the analytical data. Therefore, we want to
shortly reflect on some commonly used statistical methods
for data analysis and their application in metabolomics data
analysis. The proper way of statistical analysis depends
highly on characteristics of the data set such as: design of
the study, the data preprocessing method that was used,
aim of the study and availability of prior knowledge such
as metabolic pathway information. Therefore, the ideal
strategy to perform statistics on metabolomics data is not
limited to one single method. However, all statistics should
include some means to validate the model in order to
prevent optimistic models that don’t hold when applied in
practice. In the third paragraph of the next section an
overview of statistical tools and validation strategies
applied in metabolomics research is provided.
2.4 Validation strategy
Due to the complexity of the metabolome (hundreds up to
thousands of different metabolites), the comprehensiveness
of silylation based GC-MS methods, the elaborate sample
workup and difficulties in data processing, an extensive
method validation is needed to assess the overall perfor-
mance of the method from sample pretreatment through
data preprocessing. The Metabolomics Standardization
Initiative (MSI) provides guidelines on reporting of studies
and methods (Fiehn et al. 2006), enabling the exchange of
metabolomics methods and data. However, no guidelines
on how to validate analytical metabolomics methods and
data preprocessing tools have been provided so far.
In several guidelines the requirements for method vali-
dation of usually a limited and defined number of analytes
have been described. In quantitative procedures at least the
following validation parameters should be considered:
selectivity, calibration model (linearity and range), accu-
racy, precision (repeatability and intermediate precision)
and limit of quantification (LLOQ) (Table 3) (ICH 2005;
Peters and Maurer 2002; Thompson et al. 2002; U.S.
Department of Health and Human Services et al. 2001).
Additional parameters that are generally recommended to
be evaluated are: limit of detection, recovery, reproduc-
ibility and robustness.
In principle the same validation parameters as men-
tioned above should be considered in quantitative com-
prehensive analysis. The question remains: ‘‘How to assess
the validation parameters for a comprehensive analytical
method for metabolomics analysis’’? Ideally, the method
performance for every individual metabolite should be
assessed by spiking isotopically labeled metabolites to the
matrix of interest. However, the availability of isotopically
labeled standards is limited and such an approach would be
very time consuming and expensive, especially since
method performance can vary depending on the composi-
tion of the sample matrix studied and validation needs to be
performed in all matrices of interest. An alternative could
be to use different dilutions of a pooled sample of the
samples to be analyzed to establish the calibration model
(Koek et al. 2010b). However, only relative quantification
of metabolites is possible using this strategy as metabolite
concentrations are unknown and only linearity and preci-
sion can be determined. In addition, method performance
can differ significantly with changing matrix composition.
In general, the recovery of critical (class-3) metabolites is
lower when the amount of total sample matrix injected is
lower, and the calibration results obtained by this strategy
can deviate from the linearity obtained when similar
amounts of total biomass are injected. Another approach
could be to use standard addition of metabolites to the
matrix. However, if the metabolite of interest is present in
the matrix the LOD cannot be determined. A more feasible
and straightforward approach is the use of an extensive set
of representative isotopically labeled metabolites from
different performance classes (Sect. 2.1) with different
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functional groups, polarities and molecular mass. By per-
forming the validation for these representative metabolites
a good insight into method performance and reliability of
the analytical data for different compound classes of the
method can be obtained. Furthermore the use of repre-
sentative quality control samples (Sect. 2.5) measured
multiple times during a study can be used to assess the
precision (inter- en intra-batch) of all metabolites present in
the pooled sample.
For metabolomics studies we propose a minimum vali-
dation scheme as shown in Table 4. In this validation
scheme the calibration model, repeatability, intermediate
precision, LLOQ, recovery and matrix effect are addressed.
The guidelines proposed were derived from the FDA val-
idation guidelines for bio analysis (U.S. Department of
Health and Human Services et al. 2001) and from experi-
ence in daily practice. For initial validation of a method a
minimum number of 80 sample injections is proposed. For
studies with a limited number of samples, measured within
a few days, or when evaluating a new sample matrix a
validation with a minimum of 35 sample injections is
recommended. Obviously, when (larger) sample sets are
measured over larger periods of time or more information
on selectivity is needed, validation should be extended
accordingly, and, for example intermediate precision over a
larger period of time, stability of samples and selectivity
should be investigated.
In view of the unbiased non-targeted analysis used in
metabolomics research, some validation parameters such as
accuracy, require a different approach compared to targeted
analysis. In general, no standard reference materials (SRM)
are available for determining the accuracy of metabolomics
methods. NIST is developing a SRM for metabolites in
human blood plasma (NIST 2010), however this is still not
commercially available. In the absence of reference mate-
rials with known metabolite concentrations, we propose to
investigate the accuracy of the analytical method by
determination of the recovery of metabolites spiked to
samples. The recovery of the method (excluding the
derivatization) is determined by comparing the response of
(labeled) metabolites spiked to a biological sample prior to
the sample workup with the response of the same metabo-
lites spiked after extraction prior to derivatization (Table 4).
The derivatization recovery is not determined, due to the
absence of commercially available reference standards of
silylized metabolites. Still, when the method performance is
reproducible, quantitative results can be obtained without
knowing the actual derivatization efficiency.
As mentioned earlier, matrix effects, such as degrada-
tion or adsorption in the analytical system can differ
Table 3 Definitions of validation parameters
Selectivity The ability of an analytical method to differentiate and quantify an analyte in the presence of other components in the
sample. One way to establish method selectivity is to prove the lack of response in blank matrix, an approach not suitable
for metabolomics analysis. The second approach is based on the assumption that small interferences can be accepted as
long as precision and bias (at LLOQ level) remain within certain acceptance limits
Calibration model The relationship between the concentration of an analyte in the sample and the corresponding detector response. There is
general agreement that calibration samples should be prepared in blank matrix and that their concentrations must cover
the whole calibration range. Recommendations on how many concentration levels should be studied with how many
replicates per concentration level differ significantly. To establish a calibration model, we suggest measuring at least six
different calibration levels, evenly spread over the whole calibration range, in duplicate (Table 3)
Accuracy The closeness of mean test results obtained by the method to the true value (concentration) of the analyte. Accuracy is
determined by replicate analysis of samples containing known amounts of the analyte. Ideally, the accuracy or trueness of
an analytical method is assessed by comparing the value found with a certified reference value or ‘true’ value (Hartmann
et al. 1998; International conference on harmonisation. Q2(R1). Validation of analytical procedures: text and
methodology, 2005; Peters and Maurer 2002; Thompson et al. 2002). However, in the absence of reference materials, as is
the case in metabolomics analysis, the accuracy of an analytical method can be investigated by recovery experiments of
(isotopically labeled) metabolites spiked to samples
Precision The closeness of individual measures of an analyte when the procedure is applied repeatedly to multiple aliquots of a single
homogeneous volume of biological matrix. Three different levels of precision can be determined, i.e. repeatability,
intermediate precision and reproducibility. The repeatability or intra-batch precision is the precision over a short period of
time using the same operating condition and is determined by repeated injection of individually prepared samples of the
same test material. Intermediate precision or inter-batch precision expresses the within-laboratories variations, e.g.
different days, different analyst, different equipment, etc. Reproducibility describes the precision between different
laboratories and only has to be studied when the method is to be used in different laboratories
Limit of
quantification
The lowest amount of metabolite that can be quantified with suitable precision and accuracy (Hartmann et al. 1998;
International conference on harmonisation.Q2(R1).Validation of analytical procedures: text and methodology, 2005;
Peters and Maurer 2002; Thompson et al. 2002). The LLOQ can be based on precision and accuracy data (lowest
concentration with a precision and accuracy better than 20%), signal-to-noise or calculated from the standard deviation
(SD) of in a blank sample or preferably the lowest point of the calibration line (LLOQ = k 9 SD/slope). For LLOQ a S/N
ratio or k-factor equal to or greater than ten is usually chosen
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depending on the matrix composition. Therefore it is
important to investigate whether the same concentration of
a metabolite gives similar response in different matrices, to
justify the comparison of relative metabolite concentrations
between samples. The matrix effect is determined by
determining the ratio of the response of the metabolites
spiked after extraction and the metabolites in a standard
solution. The matrix effect calculation covers matrix
effects during derivatization (generally decreasing
response) and matrix effects during analysis (increase
(matrix enhancement; Anastassiades et al. 2003; Hajslova
and Zrostlikova 2003; Koek et al. 2006, 2008) or decrease
in response due to matrix present) (Table 4).
The selectivity is the ability of a method to differentiate
and quantify an analyte in the presence of other compo-
nents in a sample. Metabolomics samples contain large
numbers of different metabolites that are all of interest.
Therefore, the conventional ways of determining the
selectivity, i.e. proving the absence in blank samples or to
determine the precision and accuracy at the LLOQ level for
every metabolite, are not feasible. A compromise could be
to assess the selectivity (accuracy and precision) in specific
‘worst case’ scenarios, for example when analyzing
monosaccharides (e.g. hexoses) with similar molecular
weight, retention behavior and very similar mass spectra,
or in case of coelution of low-abundant metabolites with
very-high-abundant metabolites.
The evaluation of the fitness-for-purpose of a method is
the most important goal in method validation. In meta-
bolomics this means that one has to assess whether the
method is suitable to answer the underlying biological
question. This is a difficult question to answer, because it is
often not known in advance which metabolites are most
interesting (high correlation with a biological characteris-
tic), at what levels of concentration these metabolites will
be present and how small the differences in concentrations
will be. In addition, due to the large differences in physi-
cochemical properties of the metabolites targeted in the GC
based methods in metabolomics research, method perfor-
mance can differ significantly for different metabolites.
Therefore, the formulation of general acceptance criteria
for the different method-performance characteristics is
complicated. One way to overcome this constraint is to
classify metabolites in view of their analytical performance
Table 4 Proposed minimum validation of analytical metabolomics methodsa











Recovery and matrix effecte LLOQ Total
number
Number of samples on days 1–14
Day 1 Day 2 & 3, (&7,
10 and 14)d
Day 1
C0 x No 2 2
C1 x Very low 3b (5 9 3) (3 after sample preparation) f 3 (21)
C2 x Low 2 2
C3 x x Intermediate 3b 2 9 3(?3 9 3) 3 std ? 3 after sample prep.
prior to derivatization
15 (24)
C3 x Intermediate 6 9 1c 6
C4 x Higher 2 2
C5 x High 3b (5 9 3) (3 after sample preparation) 3 (21)
C6 x Highest 2 2
Total 35 (80)
a Minimum validation for initial validation of a method all samples (also the samples between brackets) should be measured. For studies with a
limited number of samples, analyzed within a few days, the samples between brackets could be discarded
b It is recommended to analyze 3 samples so that data for a calibration line can also be used for determining intermediate precision (C1, C3, C5),
recovery (C1, C3, C5) and LLOQ (C1)
c Determination of analytical repeatability, one sample injected six times
d Determination of intermediate precision over 3 days or 14 days (between brackets), analysis of three samples per day including sample
preparation
e The recovery of the extraction (excluding derivatization) can be calculated by determining the ratio between the response of the metabolites
spiked before and after extraction. The matrix effect is determined by determining the ratio of the response of the metabolites spiked after
extraction and the metabolites in a standard solution. The matrix effect calculation covers matrix effects during derivatization (generally
decreasing response) and matrix effects during analysis (increase (matrix enhancement) or decrease in response due to matrix present)
f Calculated from RSD of lowest concentration point of calibration line (LOQ = 10 9 SD/slope)
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and formulate acceptance criteria per group of metabolites
(Koek et al. 2006). Data obtained during optimization of a
metabolomics method can be used to formulate realistic
and manageable acceptance criteria. In addition, the per-
formances and results from validations of GC-based met-
abolomics methods described in literature (Sect. 3.3) can
be useful for that purpose.
2.5 Quality control
When a validated analytical method is implemented,
quality control is essential to ensure the quality and reli-
ability of the analytical data obtained. Quality control is
needed to monitor and/or correct for deviations that occur
during sample workup or analysis, as discussed in Sect. 2.1.
Other known sources of variation in metabolomics analysis
are, for instance, differences between instruments, opera-
tors, changes in instrumental sensitivity, fouling of mass
spectrometers etc. As all endogenous metabolites are of
interest and the identities of many metabolites are unknown
a priori, quality control is complex. Several strategies can
be followed to monitor the quality and correct for devia-
tions in metabolite response, such as the use of external
standards, internal standards or a combination of both
internal and external standards (Table 5). It should be
noted that quality standards should either be used for the
detection of deviations or the correction of deviations. Only
in this way quality standards for control (detection) can be
used to check the quality of the data after eventual
corrections.
External standards are especially suitable to detect and/
or correct for detector drift and to control the inertness of
the analytical system. For example, academic standards,
i.e. standard solutions without matrix, can be used as early
markers for the decline of the performance of the analytical
system, as metabolites are more prone to adsorb or degrade
on the surface of the analytical column in the absence of
sample matrix (Anastassiades et al. 2003; Hajslova and
Zrostlikova 2003; Koek et al. 2006; Koek et al. 2008).
Another very useful external standard is a pooled sample of
all individual samples (pooled QC) measured during a
study (Sangster et al. 2006). A pooled QC can be used to
calculate the repeatability and intermediate precision of all
detectable metabolites present in the samples and to correct
for detector drift and/or variations in MS response between
batches. In addition, a pooled QC representative of the
samples measured, can be used to correct MS responses of
metabolites in individual samples, as proposed by Greef
et al. (2007) and Kloet et al. (2009). However, this cor-
rection will only work when the matrix effects are not
varying between samples, e.g. when the variation of the
sample composition is limited.
With isotopically labeled metabolites or non-endoge-
nous as internal standards, disturbances can be detected or
Table 5 Different quality control standards and their function












• Storage - - - ? ?
• Extraction - - - ? ?
• Derivatization - - - ? ?
• Injection vol. - - ? - -
• Detector sensitivitya - - ? - -
• Detector driftb - ? - - -
• Inertness analytical system ? ? - ±c ±c
Correction
• Detector responsea - - ? - -
• Detector driftb - ? - - -
• Batch correction - ? ? - -
• Recovery metabolites - ± - ± ?
a Overall sensitivity of the detector
b Detector drift, i.e. the change in detector response with mass-to-charge ratio (m/z) can vary with different masses (e.g. due to fouling) and
should be addressed separately from the overall sensitivity
c The ratio of different labeled metabolites, e.g. class 3/class 1 (critical/good performing metabolite; §2.1), can be used as an indicator for the
inertness of the analytical system. However, deviations in the ratio can also be caused by other deviations, e.g. during sample workup
d Stable compound that is not derivatized and not present in biological samples
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corrected, for every single metabolite in every individual
sample. By adding labeled metabolites (e.g. prior to
extraction, derivatization or analysis) the different steps of
the sample work-up can be controlled. A endogenous
metabolite can be corrected by the addition of its isoto-
pologues (same molecule with different isotopic composi-
tion), or an isotopically labeled or non-endogenous
metabolite with different composition but similar in per-
formance characteristics (e.g. of the same class). Despite
the fact that isotopically labeled metabolites are relatively
expensive and their availability is limited, the addition of
labeled metabolites is essential to monitor and eventually
correct metabolite responses in metabolomics studies.
Another approach is to use in vivo isotopically labeled
microorganisms as internal standards. In this setup micro-
organisms are grown on isotopically labeled growth media
to label all intracellular metabolites. Extracts of this
microorganism are then mixed with non-labeled microbial
extracts, resulting in an extract containing isotopically
labeled metabolites as internal standards for every metab-
olite (Birkemeyer et al. 2005). However, these labeled
reference materials are not available for most matrices (e.g.
mammalian metabolomics), and the labeling efficiency has
to be high. In addition, the retention behavior of labeled
internal standards is very similar to the endogenous
metabolite and when silylation is used their mass spectra
can contain many similar mass fragments. Therefore,
labeled internal standards can complicate the data prepro-
cessing and quantification (e.g. deconvolution, peak pick-
ing and integration).
In this section we propose a quality control scheme
using a combination of isotopically labeled internal stan-
dards and external quality standards (Fig. 4). This scheme
is suitable for the most commonly used GC-MS methods
using an oximation and subsequent silylation as derivati-
zation prior to analysis, although it can also be used when
applying different derivatization methods or no derivati-
zation at all.
The amount of internal standards needed and how to
correct the MS response for metabolites in individual
samples depends on the variability of the sample compo-
sition. When differences between sample compositions are
small (e.g. plasma or serum) the differences in matrix
effects between different samples can be expected to be
small as well. In that case the correction of individual
metabolites can be performed by using an external stan-
dard. In these studies we suggest using a set of at least six
labeled metabolites as internal standards for quality con-
trol. Three standards should be added before extraction
(one for every performance class; cf. Sect. 2.1, i.e. favor-
able as well as unfavorable metabolites), and three (one for
every performance class) added before derivatization. In
addition, at least one exogenous standard, i.e. a stable
compound that is not derivatized, should be added to every
sample before injection to correct for injection volume and
MS response; this is the only internal standard used for
correction purposes. To monitor and eventually correct for
differences in the MS response within or between batches
for all individual metabolites a pooled QC should be ana-
lyzed repeatedly, for example at the beginning and end of a
batch of samples and between every set of five samples.
The pooled QC is used to calculate the repeatability and
precision of response for each metabolite. In common
practice, the correction for small variations in injection
volume and MS response with the internal standard
described above is always performed. If needed, for
example in large studies when differences between batches
are significant, each metabolite can be corrected by using
the QC samples (Kloet et al. 2009). In Fig. 5 the effects of
IS and QC correction are illustrated in a real-life study.
During the analysis of this study, consisting of 5 batches of
urine samples (total of approximately 200 samples), the
MS-ion source was replaced between batch 3 and 4,
causing an offset in the peak areas between batch 3 and 4.
As an example, the MS response of phenylalanine could be
corrected properly by correction on only the internal
standard (dicyclohexylphthalate), however the peak area of
glycolic acid was only properly corrected for after IS and
QC correction.
When the differences in matrix composition are larger,
for example microbial samples, the pooled QC generally
cannot be used to correct for variations in MS response
for individual samples. In these studies the matrix effects
can differ between samples and a correction with an
external standard could even decrease the reliability of
the data. In these cases, the set of internal standards
added before extraction should be extended. Especially,
labeled metabolites from compound classes that are more
prone to degradation or adsorbtion on the surface of the
analytical column (performance class 3, e.g. thiols,
amides and amines, Koek et al. 2006), should be added
to be able to control or correct for matrix-dependent
variations in metabolite responses for individual
samples.
Still the pooled QC is useful to monitor detector drift,
monitor the inertness of the analytical column and to cal-
culate the repeatability and precision of response for all
metabolites. In addition, the pooled QC samples can be
used to determine the most suitable internal standard to
correct for deviations from the extended set of corrective
internal standards for every individual metabolite.
Besides the use of internal standards and pooled QC, the
quality of the sample work-up and/or analysis can be fur-
ther controlled by repeated sample workup and/or injection




Based on daily practice we find that RSDs (without QC
correction) of internal quality control standards (from
compound classes: organic acids, sugars, amino acids)
within one batch are generally less than 5% (repeatability)
and 10–15% between batches within one study (interme-
diate precision). However, the method performance
depends on both the physicochemical properties of the
metabolite measured and the matrix (plasma, urine,
microbial, tissue) and may therefore deviate from the
values mentioned above (Koek et al. 2006). Therefore, as
already mentioned in Sect. 2.4, different acceptance
criteria are set depending on the compound class and
matrix.
3 Data processing, data analysis, method validation
and quality control in literature
In Table 2 an overview of GC based applications in meta-
bolomics research is presented. Publications were only
included in Table 2 when the number of targeted compound
classes was three or higher. Research on metabolic target
analysis or metabolic profiling was not included, as a dif-
ferent approach for method development and validation is
usually applied for these targeted analyses than for non-tar-
get comprehensive analysis. In the next sections the data-
processing strategies, data-analysis tools, method validation
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Add IS: labeled 
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Improve inertness of 
analytical system, 
e.g. change liner or 
remove part of 
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All samples and a 





Add IS: labeled 
metabolites 
(optional a)) 
Fig. 4 Suggested quality-
control scheme for GC-MS
metabolomics studies; IS
internal standard(s), QC quality-
control sample. a)Depending on
the matrix analyzed, one can
choose to add IS for correction
or leave these standards out (see
Sect. 2.5)
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3.1 Data preprocessing
As mentioned in Sect. 2.2, there are three ways to pre-
process GC-MS data: target analysis, peak picking and
deconvolution.
In one-dimensional GC-MS often a targeted approach is
followed to obtain a list of metabolites and their corre-
sponding peak areas. For example, Weckwerth et al.
(2004a) used a customized reference-spectrum database
based on retention indices and mass-spectral similarities to
match peaks between chromatograms. Metabolites were
quantified using a selective fragment ion for each indi-
vidual metabolite from their corresponding mass spectrum.
Morgenthal et al. (2005) reported a similar approach with
the addition of first defining a reference chromatogram
with a maximum number of detected peaks that fulfill a
predefined signal to noise ratio.
In peak picking, first the m/z traces containing mean-
ingful information are selected, for example with CODA
(Windig and Smith 2007), MetAlign (Lommen 2009) or
Impress (van Greef et al. 2004b), then the peaks in the
selected ion traces are detected using methods such as the
second derivative and finally integrated to obtain single
intensity measures for complete peak profiles. For GC-MS
data this results in a data table, in which one metabolite is
represented by many different variables (all masses present
in the mass spectrum are separately integrated). Due to this
major drawback, peak picking is not frequently used with
GC-MS data, and only few examples using this strategy are
reported in literature (Lommen 2009; Tikunov et al. 2005).
Deconvolution has been applied for both one-dimen-
sional (1D) and two-dimensional (2D) datasets. For
example, Jonsson et al. (2005) and Jellema et al. (2010)
demonstrated the advantage of simultaneous deconvolution
Fig. 5 Example of the effects of correction of peak areas of
phenylalanine (a) and glycolic acid (b) measured in 5 consecutive
batches (approximately 35 samples per batch, total of 180 samples);
on the x-axis: sample number, and on the y-axis: (normalized) peak
areas. Upper: absolute peak areas of uncorrected data, middle:
normalized peak areas after IS correction, lower: normalized peak
areas after IS and QC correction. In blue: regular samples, in red: QC
samples, in green: blank samples and in turquoise: QC validation
samples (the same as QC samples, but not used for correctional
purposes) (Color figure online)
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of all 1D-GC-MS chromatograms at the same time, rather
than processing each chromatogram separately and subse-
quently construct a total data set afterwards from the sep-
arate peak tables per chromatogram. In all evaluated
GC 9 GC-MS papers a deconvolution approach was used,
when quantitative data on peak areas was extracted from
raw chromatograms. Two different software packages were
used, i.e. ChromaTOF software (LECO, St. Joseph, MI,
USA) (Huang and Regnier 2008; Koek et al. 2008; Kusano
et al. 2007; O’Hagan et al. 2007; Oh et al. 2008; Shellie
et al. 2005; Welthagen et al. 2005) or parallel factor
analysis (PARAFAC; Harshman 1970) (Guo and Lidstrom
2008; Hope et al. 2005b; Humston et al. 2008; Mohler et al.
2006; Mohler et al. 2007; Mohler et al. 2008; Sinha et al.
2004a, b). Although deconvolution was used in all
described papers, only few authors used a non-targeted
approach in metabolite quantification (Lee and Fiehn 2008;
O’Hagan et al. 2007; Oh et al. 2008; all ChromaTOF
users). Almost no quantitative data has been reported on
the performance of the deconvolution software tools in
non-targeted metabolite quantification. Data on the per-
formance that has been published is only for a selected
number of target metabolites after deconvolution and peak
merging of different modulations (see §3.5). Only Koek
et al. (2010a) evaluated the performance of non-target
processing in GC 9 GC-MS using the ChromaTOF soft-
ware; for approximately 70% of all peaks accurate peak
areas could be obtained without manual correction of
integration and peak merging. Still, the time required for
processing limited the use of the ChromaTOF software for
non-target processing (quantification of all metabolites) in
large metabolomics studies ([30–50 samples, eventually in
duplicate). PARAFAC was used only in a targeted
approach, i.e. first a multivariate classification method on
segments of aligned raw chromatograms was performed
(with the Fisher ratio method (Guo and Lidstrom 2008;
Humston et al. 2008; Mohler et al. 2006; Mohler et al.
2007; Mohler et al. 2008) or DotMap algorithm (Hope
et al. 2005b; Sinha et al. 2004b)) and subsequently
PARAFAC was applied only on time segments of the raw
data that discriminate between the different groups of
interest. Although PARAFAC could be applied in non-
targeted quantification of an entire GC 9 GC-MS chro-
matogram (Hoggard and Synovec 2008), the time required
to process a single chromatogram (tens of hours, excluding
the time-consuming task of ensuring only one entry per
metabolite in all samples) is still a major bottleneck to
apply PARAFAC for non-target processing.
Oh et al. (2008) developed a GC 9 GC-MS tool to deal
with the difficult task of peak merging and ensuring only
one entry per metabolite. Their peak sorting algorithm is
based on retention time, correlation of mass spectral
information and (optional) peak name which are reported
after initial processing (deconvolution and peak integration)
by the ChromaTOF software. First the second dimension
peaks originating from the same chemical component are
merged starting at the first entry of both the first and second
dimension run. For both the first- and second-dimension
retention time an allowed deviation in retention time is
defined. When a peak stays within the allowed retention-
time shifts then the underlying mass spectra are compared
using the Pearson correlation coefficient (R). The second
step in the algorithm then uses a sorting scheme to match
equal peaks from different chromatograms. The chromato-
gram with the most peaks is assigned as the reference
sample. Starting with the first peak the sorting algorithm
searches for peaks that match as closely as possible the
same criteria as were used in the merging step: retention
time shifts in the first and second dimension should be less
than a preset maximum allowable shift; the Pearson corre-
lation coefficient between the mass spectra should meet a
preset minimum correlation and (optional) the peak names,
as assigned by the ChromaTOF software, should be the
same. All matches are recorded in a new table and the
processed peaks are removed from the list, resulting finally
in a peak table representing all peaks in all chromatograms.
Unfortunately, only qualitative data and no quantitative
data on the performance of the software are given.
De Souza et al. (2006) also worked on an algorithm to
obtain a single entry per metabolite in all samples, using
the peak lists extracted from the raw data by commercial
software (ChemStation, Agilent Technologies, Santa Clara,
CA, USA). First hierarchical clustering of retention times
within replicate measurements was performed resulting in
a dendrogram illustrating the distances between the reten-
tion times of all detected peaks. The cut-off to determine
clusters within the dendrogram was based upon the average
number of peaks within the replicate measurements. In a
next step the clustered peaks from the replicate measure-
ments are again clustered in a second step to cumulate
peaks with the same identity but measured within samples
of, for example, different cell states or genotypes. So-called
super-clusters are formed which in an ideal situation con-
tain, per cluster, the same peak or metabolite as measured
within the complete dataset.
3.2 Data analysis
Broadly viewed, data from metabolomics studies are either
analyzed using univariate tests from classical statistics,
such as the Student t-test (Denkert et al. 2006), or using
multivatiate statistics, such as PCA (Denkert et al. 2006)
and all sorts of regression and classification methodologies.
Key to the success of all statistics is to have both a good
statistical validation as well as reliable biological inter-
pretation of the results. Metabolomics data does not fit well
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to the assumption of normal distribution or the assumption
of having more samples ‘n’ than variables ‘m’ per subject
or data record. In metabolomics typically the number of
variables or metabolites (‘m’) is much larger than the
number of samples measured (‘n’). This type of data is also
referred to as megavariate data (Rubingh et al. 2009).
Given various distributions, the chance of detecting a dis-
criminating variable with a probability of for instance more
than 99.9% (P \ 0.01) is increased proportional to the
number of independent tests one performs. In metabolo-
mics studies often the number of variables is extremely
high in comparison to the number of samples and care
should be taken not to introduce chance to the scene of
marker selection (Broadhurst and Kell 2006).
One way to reduce the chance of finding a coincidental
significant effect in univariate data analysis is to take into
account the ‘False Discovery Rate’ or FDR (Broadhurst
and Kell 2006) using a corrected level of the P-value
according to Bonferroni. The P-value for instance in the
t-test is thereby reduced such that the chance of obtaining a
false discovery due to multiple testing is made proportional
to the number of tests being performed. This methodology
has been introduced rather recently into metabolomics
(Broadhurst and Kell 2006), earlier Fiehn et al. (2000a),
Weckwerth et al. (2004b) used a standard P-value to test
differential changes. While in the Bonferroni correction
methodology the problem of false positives is tackled, it
also introduces a problem, because significance levels
are rather difficult to reach. For instance, in the case of a
P-value of 0.05 and 1000 metabolites, the Bonferroni
corrected P value becomes 0.00005. Broadhurst and Kell
(2006) suggest some alternatives that take into account the
internal correlation structure of the data. Denkert et al.
(2006) validated differentiating peaks by means of random
permutations of the classification vector, meaning that
samples obtain a random classification as being a member
of a certain class. This resulted in an expected number of
false positive discoveries (nexp) and an observed number of
discoveries (nobs).
Other methodologies to analyze megavariate data all try
to combine the original variables into a set of newly
defined variables that are linear combinations of the ori-
ginal variables. Such methods include principal-component
analysis (PCA), principal-component discriminant analysis
(PCDA) and partial-least-square discriminant analysis
(PLS-DA). An overview of methodologies for data analysis
in metabolomics research is given by Greef and Smilde
(2005). Among these methodologies PCA is very popular
and powerful. For example, Fiehn et al. (2000a), Jonsson
et al. (2004) and Denkert et al. (2006) use PCA to find
metabolites that differentiate between different samples.
Pierce et al. (2006b) use PCA to find regions in GC 9 GC-
TOFMS chromatograms that differentiate between samples
and subsequently, use PARAFAC (Sinha et al. 2004b) to
deconvolute these regions of interest. Another statistical
method to find regions that differentiate between samples
in GC 9 GC-MS data is the Fisher ratio method (Mohler
et al. 2007; Pierce et al. 2006a). The Fisher ratio method
can be applied directly on the four dimensional (4D) data
structure from a GC 9 GC-TOF-MS instrument (no prior
processing) and statistically differentiates regions of the
signals containing large class-to-class variations from
regions containing large within-class variations.
Another popular method to analyze megavariate data is
hierarchical cluster analysis or HCA. HCA calculates
Euclidian distances resulting in groups or clusters of
samples that show multivariate similarity. The calculated
distances are represented into dendograms where alike
metabolic profiles are clustered together (e.g. Fiehn et al.
2000a).
In multivariate statistics methods have been introduced
to reduce the probability to obtain correlations by chance.
Methods such as cross validation, permutation tests and,
most optimal, the use of separate datasets for training,
validation and testing can be used for this purpose. Denkert
et al. (2006) validated the markers that distinguish between
ovarian carcinomas and borderline tumors by calculating
the P-value for all significant metabolites after permuting
or randomizing the classification factors. This led to the
conclusion that all discovered metabolites perform better
than chance. Dixon et al. (2007) used PLS-DA to find
significant variables and proposed to use different strate-
gies for either biomarker selection (discriminatory marker
selection) or estimation of the predictive ability of a clas-
sification model. To determine potential biomarkers all
samples were included in the model rather than using a
separate training set. In case of a predictive model, the total
dataset was split up into a training and a test set. Next, the
training set was split up multiple times using a bootstrap
methodology resulting in a bootstrap set and a validation
set. A similar methodology is applied and explained by
Westerhuis et al. (2008) whereby a class membership
confidence measure can be estimated for each sample.
3.3 Method validation
Although GC-MS is considered a mature technique and is
frequently used in metabolomics analysis, method valida-
tion has not had much attention in metabolomics research
so far. Nearly all publications focus on the application and/
or data preprocessing and data analysis rather than evalu-
ating the method performance.
Some methods are described that use headspace sam-
pling (HS) and/or solid-phase micro extraction of the
headspace (HS-SPME) without a preceding sample
workup, to introduce the metabolites in the analytical
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column (Table 4). Data on method validation of these
methods is limited. Only Pauling et al. (1971) reported data
on the application range (250–280 different metabolites
measured) and intermediate precision (*10%). Because
headspace sampling is used to introduce the sample, the
application range of such methods is restricted to volatile
metabolites.
The majority of the validation data available is on
one-dimensional GC-MS methods using oximation and
subsequently silylation as derivatization technique (OS-
GC-MS). Due to the general applicability of silylation,
these types of methods cover the largest range of different
compound classes, including alcohols, aldehydes, amino
acids, amines, (phospho-) organic acids, sugars, sugar
acids, (acyl-) sugar amines, sugar phosphates, purines and
pyrimidines. The repeatability is the validation parameter
that is most assessed and reported. Only few papers report
data on other validation parameters, such as selectivity,
calibration model, accuracy (recovery), intermediate pre-
cision and LLOQ (Table 5). Typically, metabolite
responses are linear over at least two orders of magnitude,
recoveries between 70 and 140% are found. Furthermore,
repeatability and intermediate precision of the sample work
up and analysis are reported of 1–15% and 7–15%,
respectively and detection limits in the range of 40–500 pg
on-column. However, due to the derivatization, method
performance is significantly influenced by the compound
class or functional groups of a metabolite. The performance
for critical (less stable) compounds (e.g. thiols and amides)
highly depends on the inertness of the analytical system
(Koek et al. 2006).
One extensively validated method with an alternative
derivatization strategy is reported by Qiu et al. (2007) In
this paper an ethyl-chloroformate derivatization is used
prior to GC-MS analysis. Although chloroformate reagents
only convert amine and carboxylic functional groups,
limiting the application range to amines, amino acids and
organic acids, the derivatization can be performed directly
in the sample without prior removal of water and the
reaction is very fast (60s) and the complete sample work up
procedure takes less than 10 min. The results for linearity,
accuracy, precision and detection limits are comparable to
the results for oximation/silylation based methods.
Although this method can be interesting when high
throughput of samples is necessary, the application range
of this method is limited compared to OS-GC-MS methods.
Apart from the one-dimensional GC-MS methods some
two-dimensional gas chromatography (GC 9 GC) methods
are described relying on oximation and silylation. The
focus in these papers is mainly on data processing and data
analysis but validation data are very limited. Some report
the repeatability of injection (typically 5–10%) and/or the
repeatability of the sample workup and analysis (typically
11–31%). Only Koek et al. (2008) describe a more elabo-
rate validation covering selectivity, calibration model,
repeatability and lower limit of detection (LLOD). Com-
pared to one-dimensional OS-GC-MS higher peak capacity
and lower detection limits (2–20 times improved) were
obtained. Due to the use of a thicker film column
(0.32 mm 9 0.25 lm film thickness) in the second
dimension the inertness of the analytical system improved,
resulting in better linear ranges (lower intercepts) espe-
cially for critical compounds (Koek et al. 2008). In addi-
tion, the performance of the method for a set of test
metabolites was stable in samples with varying matrix
compositions, allowing accurate (relative) quantification.
In view of these improvements OS-GC 9 GC-MS methods
are capable of providing more detailed and improved
information on sample compositions in metabolomics
studies. However, data preprocessing and analysis is still
very complex and time-consuming, due to limitations of
the software currently available (Koek et al. 2010a).
3.4 Quality control
Only few paper were published on quality control in met-
abolomics studies. Sangster et al. (2006) suggested the use
of a pooled sample from all study samples as a quality
control sample. Initially, a small set of selected metabolites
were visually inspected on peak shape, MS response, mass
accuracy and retention time and subsequently the whole
dataset was analyzed using PCA. In a good dataset QC
samples were expected to cluster close together and show
no time related trends. The use of PCA can be a very useful
tool for a quick evaluation of the analytical data quality.
However, it should be noted that even when quality control
samples cluster together in PCA analysis, still deviations
for individual metabolites can exists. Fiehn et al. (2008)
used daily quality control samples. For this purpose, two
method blanks and four calibration curve samples were
used consisting of 31 pure reference compounds. Although
this strategy gives information on the state of the analytical
system at the beginning of a day, no information on the
performance for individual samples is obtained. Further-
more Koek et al. (2006) describe a quality control strategy
using isotopically labeled internal standards added prior to
extraction and derivatization. The internal standards were
used to control the quality of analysis and eventually to
correct for disturbances during sample work-up.
4 Conclusions and perspectives
The purpose of metabolomics research is to gain under-
standing in the functioning of organisms and biological
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systems and to answer biological questions. Quantitative,
reliable analytical data on (relative) metabolite concentra-
tions is a prerequisite to achieve this goal.
GC-MS analysis is very suitable for comprehensive non-
target analysis, and a large range of different metabolites
can be measured when derivatization with a silylation
reagent is used. Although derivatization coupled with GC-
MS is frequently applied in today’s metabolomics research,
method validation data described in literature is surpris-
ingly limited. Especially, important information on inter-
mediate precision and accuracy in GC 9 GC-MS is
lacking. Reliable data is needed to validate the comparison
of relative metabolite concentrations or ultimately to
determine absolute metabolite concentrations in meta-
bolomics samples, but this has to be based on satisfactory
validation of linearity, intermediate precision and accuracy.
In most metabolomics studies the relative concentrations of
metabolites in different samples are compared, rather than
comparing absolute concentrations, and in this approach
the precision of a method is more important than the
absence of bias. However, it still has to be investigated
whether the relative quantification is correct, i.e. will the
same amount of metabolite provide the same peak area in
all matrices of interest? This is very critical, because dif-
ferences in matrix compositions can significantly influence
the recovery of metabolites.
The ultimate goal in metabolomics is to determine the
absolute concentration levels for all metabolites in a sam-
ple. However, the largest bottleneck in absolute quantifi-
cation is the difficulty in determining the accuracy of
metabolomics methods. Presently no certified reference
materials are available to determine the accuracies of
metabolomics methods. In both setups, however, when the
guidelines on method validation and quality control in this
paper are followed (addition of extensive set of represen-
tative internal standards and determination of the calibra-
tion model by adding labeled standards to the matrix)
relative or absolute quantification is possible. Still, the
development of certified reference materials for meta-
bolomics analysis is needed to achieve absolute quantifi-
cation for all metabolites.
Besides the analytical method, data processing is
essential in obtaining quantitative and unbiased analytical
data. Deconvolution approaches, in principle, fit all
requirements for metabolomics analysis, such as, handling
of huge data sets and unbiased quantification. Nevertheless,
the precision of deconvolution approaches compared to
targeted approaches is still lower. Especially in GC 9 GC-
MS, where target analysis is not a realistic option,
improvement of the speed and precision of the processing
tools is required to be able to handle large data sets
([30–50 samples).
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